Functional characterization of adherent synovial fluid cells in rheumatoid arthritis: Destructive potential in vitro and in vivo

Arthritis and Rheumatism

Volumn 48, Issue 7, 2003, Pages 1873-1880

  Neidhart, Michel ^a,b   Seemayer, Christian A ^a   Hummel, Klaus M ^a   Michel, Beat A ^a   Gay, Renate E ^a   Gay, Steffen ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Center of Experimental Rheumatology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; COLLAGEN; DECAY ACCELERATING FACTOR; GALECTIN 3; GLYCOSAMINOGLYCAN POLYSULFATE; INTERCELLULAR ADHESION MOLECULE 1; INTERSTITIAL COLLAGENASE; MARIMASTAT; MATRIX METALLOPROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE DEGENERATION; CELL ACTIVITY; CELL ADHESION; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCID MOUSE; SYNOVIAL FLUID;

ADULT; ANIMALS; ARTHRITIS, RHEUMATOID; CARTILAGE; CELL ADHESION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; FIBROBLASTS; GLYCOSAMINOGLYCANS; HUMANS; HYDROXAMIC ACIDS; MALE; MATRIX METALLOPROTEINASE 1; MICE; MICE, SCID; MICROSCOPY, ELECTRON; MIDDLE AGED; PHENOTYPE; SYNOVIAL FLUID;

EID: 0037667300     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11166     Document Type: Article

References (20)

1. Hasselbacher P. Synovial fluid analysis. In: Utzinger PD, Zvaifler NJ, Ehrlich GE, editors. Rheumatoid arthritis. Philadelphia: JB Lippincott; 1985. p. 193-208.
2. Mackay JMK, Panayi G, Neill WA, Robinson A, Smith W, Marmion BP, et al. Cytology of rheumatoid synovial cells in culture. I. Composition and sequence of cell populations in cultures of rheumatoid synovial fluid. Ann Rheum Dis 1974;33:225-33.
3. Panayi GS, Mackay JM, Neill WA, McCormick JN, Marmion BP, Duthie JJ. Cytology of rheumatoid synovial cells in culture. II. Association of polykaryocytes with rheumatoid and other forms of arthritis. Ann Rheum Dis 1974;33:234-9.
4. Schwachula A, Rieman D, Kehlen A, Langner J. Characterization of the immunophenotype and functional properties of fibroblast-like synoviocytes in comparison to skin fibroblasts and umbilical vein endothelial cells. Immunobiol 1993;190:67-92.
5. Björnsson S. Quantification of proteoglycans as glycosaminoglycans in biological fluids using an Alcian blue dot plot analysis. Anal Biochem 1998;256;229-37.
6. Hiraoka K, Sasaguri Y, Komiya S, Zenmyo M, Inoue A, Morimatsu M. Effects of lipid peroxide on production of matrix metalloproteinase 1 (tissue collagenase) and 3 (stromelysin) and tissue inhibitor metalloproteinase 1 by human rheumatoid synovial fibroblasts. Exp Mol Pathol 1993;59:169-76.
7. Konttinen YT, Ainola M, Valleala H, Ma J, Ida H, Mandelin J, et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999;58:691-7.
8. Yu AE, Hewitt RE, Connor EW, Stetler-Stevenson WG. Matrix metalloproteinases: novel targets for directed cancer therapy. Drug Aging 1997;11:229-44.
9. Millar AW, Brown PD, Moore J, Galloway WA, Cornish AG, Lenehan TJ, et al. Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers, Br J Clin Pharmacol 1998;45:21-6.
10. Scott KA, Wood EJ, Karran EH. A matrix metalloproteinase inhibitor which prevents fibroblast-mediated collagen lattice contraction. FEBS Lett 1998;441:137-40.
11. Wojtowicz-Praga SM, Torri J, Johnson M, Stehen V, Marschall J, Ness E, et al. Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administrated orally to patients with advanced lung cancer. J Clin Oncol 1998;16:2150-6.
12. Sykes AP, Bhogal R, Brampton C, Chander C, Whelan C, Parsons ME, et al. The effect of an inhibitor of matrix metalloproteinases on colonic inflammation in a trinitrobenzenesulphonic acid rat model of inflammatory bowel disease. Aliment Pharmacol Ther 1999;13:1535-42.
13. Muller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996;149:1607-15.
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. Palmer DG. Relationship between rheumatoid cells in culture. Ann Rheum Dis 1975;34:235-8.
16. Pulkki K, Vuorio E, Jalava S. The effect of rheumatoid synovial fluid macrophages on DNA, glycosaminoglycan and collagen synthesis by synovial fibroblasts. Rheumatol Int 1983;3:133-8.
17. Santiago-Schwarz F, Sullivan C, Rappa D, Carsons SE. Distinct alterations in lineage committed progenitor cells exist in the peripheral blood of patients with rheumatoid arthritis and primary Sjogren's syndrome. J Rheumatol 1996;23:439-46.
18. Marinova-Mutafchieva L, Taylor P, Funa K, Maini RN, Zvaifler NJ. Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint. Arthritis Rheum 2000;43:2046-55.
19. Zvaifler NJ, Marinova-Mutafchieva L, Adams G, Edwards CJ, Moss J, Burger JA, et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2000;2:477-88.
20. Neidhart M, Gay RE, Gay S. Anti-interleukin-1 and anti-CD44 interventions inhibit destruction in an in vitro model for cartilage invasion by synovial fibroblasts derived from patients with rheumatoid arthritis. Arthritis Rheum 2000;43:1719-28.